CME Group Inc. (CME)
- Previous Close
213.14 - Open
213.14 - Bid 211.26 x 100
- Ask 211.68 x 300
- Day's Range
211.20 - 213.57 - 52 Week Range
175.73 - 223.80 - Volume
550,593 - Avg. Volume
1,677,814 - Market Cap (intraday)
76.105B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
24.07 - EPS (TTM)
8.78 - Earnings Date Jul 24, 2024 - Jul 29, 2024
- Forward Dividend & Yield 8.65 (4.06%)
- Ex-Dividend Date Jun 7, 2024
- 1y Target Est
227.54
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.
www.cmegroup.com3,565
Full Time Employees
December 31
Fiscal Year Ends
Sector
Financial Data & Stock Exchanges
Industry
Recent News: CME
Performance Overview: CME
Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CME
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CME
Valuation Measures
Market Cap
76.74B
Enterprise Value
78.61B
Trailing P/E
24.28
Forward P/E
22.08
PEG Ratio (5yr expected)
8.52
Price/Sales (ttm)
13.63
Price/Book (mrq)
2.83
Enterprise Value/Revenue
13.97
Enterprise Value/EBITDA
17.02
Financial Highlights
Profitability and Income Statement
Profit Margin
56.94%
Return on Assets (ttm)
1.47%
Return on Equity (ttm)
11.73%
Revenue (ttm)
5.62B
Net Income Avi to Common (ttm)
3.16B
Diluted EPS (ttm)
8.78
Balance Sheet and Cash Flow
Total Cash (mrq)
1.56B
Total Debt/Equity (mrq)
14.26%
Levered Free Cash Flow (ttm)
2.38B
Research Analysis: CME
Company Insights: CME
CME does not have Company Insights